A. Munder

B. Tümmler, M. van Griensven, H. Hedrich, 2002, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Lung infection caused by Pseudomonas aeruginosa in a CD26/DPP4 deficient F344 rat model

J. Schipke, A. Schmiedl, A. Munder, 2019, Inflammation Research.

In vivo imaging of bioluminescent Pseudomonas aeruginosa in an acute murine airway infection model.

J. Klockgether, B. Tümmler, L. Wiehlmann, 2014, Pathogens and disease.

The Role of Pseudomonas aeruginosa ExoY in an Acute Mouse Lung Infection Model

R. Seifert, A. Munder, Christina Kloth, 2018, Toxins.

Beneficial Effects of TLR-2/6 Ligation in Pulmonary Bacterial Infection and Immunization with Pseudomonas aeruginosa

B. Tümmler, R. Pabst, A. Munder, 2010, Inflammation.

A New Role of the Complement System: C3 Provides Protection in a Mouse Model of Lung Infection with Intracellular Chlamydia psittaci

B. Tümmler, A. Klos, Katrin Janik, 2012, PloS one.

Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections

A. Schambach, D. Jonigk, T. Moritz, 2018, Nature Communications.

The Pseudomonas aeruginosa ExoY phenotype of high-copy-number recombinants is not detectable in natural isolates

J. Klockgether, R. Seifert, B. Tümmler, 2018, Open Biology.

Assessing Pseudomonas virulence using mammalian models: acute infection model.

B. Tümmler, A. Munder, 2014, Methods in molecular biology.

cCMP and cUMP occur in vivo.

R. Seifert, B. Tümmler, V. Kaever, 2015, Biochemical and biophysical research communications.

Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections

A. Schambach, D. Jonigk, T. Moritz, 2018, Nature Communications.

Origins of cystic fibrosis lung disease.

B. Tümmler, A. Munder, 2015, The New England journal of medicine.

Friend or foe: genetic and functional characterization of plant endophytic Pseudomonas aeruginosa.

B. Tümmler, J. Raaijmakers, A. Munder, 2013, Environmental microbiology.

Rescue from Pseudomonas aeruginosa airway infection via stem cell transplantation.

Adan Chari Jirmo, A. Schambach, D. Wedekind, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Caenorhabditis elegans Semi-Automated Liquid Screen Reveals a Specialized Role for the Chemotaxis Gene cheB2 in Pseudomonas aeruginosa Virulence

B. Tümmler, A. Filloux, S. de Bentzmann, 2009, PLoS pathogens.

Lung function and inflammation during murine Pseudomonas aeruginosa airway infection.

B. Tümmler, G. Hansen, D. Neumann, 2011, Immunobiology.

Head-Out Spirometry Accurately Monitors the Course of Pseudomonas aeruginosa Lung Infection in Mice

F. Stanke, B. Tümmler, U. Baumann, 2010, Respiration.

Self-assembled peptide–poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis

Joseph Rosenecker, Peter Braubach, Carsten Rudolph, 2019, Nature Nanotechnology.

Fitness of Isogenic Colony Morphology Variants of Pseudomonas aeruginosa in Murine Airway Infection

B. Tümmler, L. Wiehlmann, A. Munder, 2008, PloS one.

Acute intratracheal Pseudomonas aeruginosa infection in cystic fibrosis mice is age-independent

D. Wedekind, B. Tümmler, E. Gulbins, 2011, Respiratory research.

Impaired TLR4 and HIF expression in cystic fibrosis bronchial epithelial cells downregulates hemeoxygenase-1 and alters iron homeostasis in vitro.

B. Tümmler, A. Guenther, B. Schmeck, 2014, American journal of physiology. Lung cellular and molecular physiology.

Bacterial distribution in lung parenchyma early after pulmonary infection with Pseudomonas aeruginosa

R. Pabst, A. Schmiedl, A. Munder, 2010, Cell and Tissue Research.

Competitive survival of clonal serial Pseudomonas aeruginosa isolates from cystic fibrosis airways in human neutrophils.

Adan Chari Jirmo, B. Tümmler, M. Mörgelin, 2023, iScience.

Pseudomonas aeruginosa ExoY, a cyclic GMP- and cyclic UMP-generating nucleotidyl cyclase

R. Seifert, E. Kostenis, B. Tümmler, 2013, BMC Pharmacology and Toxicology.

Pseudomonas aeruginosaExoY, a cyclic GMP- and cyclic UMP-generating nucleotidyl cyclase

E. Kostenis, B. Tümmler, V. Kaever, 2013, BMC Pharmacology and Toxicology.

A VirB4 ATPase of the mobile accessory genome orchestrates core genome-encoded features of physiology, metabolism, and virulence of Pseudomonas aeruginosa TBCF10839

J. Klockgether, L. Eberl, B. Tümmler, 2023, Frontiers in cellular and infection microbiology.

Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa

T. Marlovits, K. Rox, J. Rybniker, 2023, Cell.

Variation in the response to antibiotics and life-history across the major Pseudomonas aeruginosa clone type (mPact) panel

J. Klockgether, Leif Tueffers, A. Munder, 2024, bioRxiv.

Analysis of CFTR mRNA and Protein in Peripheral Blood Mononuclear Cells via Quantitative Real-Time PCR and Western Blot

F. Stanke, A. Munder, Silke Hedtfeld, 2024, International journal of molecular sciences.